| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &CFO
1 company
Coyne Terrance P. is an EVP &CFO at Royalty Pharma plc. Recent SEC Form 4 filings include 0 buys and 20 sells.
Estimated insider holdings value: $2.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | RPRX Royalty Pharma Plc | EVP &CFO | Sell | 34,791 | $49.78 | $1,731,840.31 | -46.4% | - | - | |
| Jan 2, 2026 | RPRX Royalty Pharma Plc | EVP &CFO | Sell | 69,582 | $38.42 | $2,673,041.24 | -12.2% | +25.0% | - | |
| Dec 15, 2025 | RPRX Royalty Pharma Plc | EVP &CFO | Sell | 69,582 | $38.36 | $2,669,172.48 | -10.9% | +19.6% | - | |
| Dec 1, 2025 | RPRX Royalty Pharma Plc | EVP &CFO | Sell | 69,582 | $39.87 | $2,773,956.01 | -9.8% | +19.0% | - | |
| Nov 24, 2025 | RPRX Royalty Pharma Plc | EVP &CFO | Sell | 69,582 | $38.55 | $2,682,505.45 | -4.6% | +14.4% | - | |
| Nov 17, 2025 | RPRX Royalty Pharma Plc | EVP &CFO | Sell | 69,594 | $39.30 | $2,735,329.16 | -8.2% | +16.0% | - | |
| Aug 10, 2023 | RPRX Royalty Pharma Plc | EVP &CFO | Sell | 75,000 | $30.73 | $2,305,027.50 | -4.4% | -9.6% | -14.1% | |
| Jul 13, 2023 | RPRX Royalty Pharma Plc | EVP &CFO | Sell | 75,000 | $31.00 | $2,325,213.75 | -4.1% | -11.6% | -12.8% | |
| Nov 8, 2022 | RPRX Royalty Pharma Plc | EVP &CFO | Sell | 24,500 | $43.47 | $1,065,012.55 | -2.5% | -10.0% | -35.0% | |
| Nov 2, 2022 | RPRX Royalty Pharma Plc | EVP &CFO | Sell | 5,500 | $43.06 | $236,845.95 | -0.6% | -6.9% | -34.7% |